Abeona (ABEO) CFO sells 24,880 shares to cover taxes on vested stock

Rhea-AI Filing Summary

Abeona Therapeutics Inc. Chief Financial Officer Joseph Walter Vazzano reported an open-market sale of 24,880 shares of common stock at a weighted average price of $6.9637 per share. According to the filing, this sale was made to cover tax obligations tied to the vesting of restricted stock awards.

After this transaction, he directly holds 493,557 shares of Abeona common stock. The price reflects multiple trades executed between $6.86 and $7.04 per share.

Insider Trade Summary

Net Seller: 24,880 shares ($173,257)

Net Sell 1 txn

Insider Vazzano Joseph Walter

Role Chief Financial Officer

Sold 24,880 shs ($173K)

Type	Security	Shares	Price	Value
Sale	Common Stock	24,880	$6.9637	$173K

Holdings After Transaction: Common Stock — 493,557 shares (Direct)

Footnotes (1)

1. The sale reported in this Form 4 was to cover tax obligations associated with the vesting of restricted stock awards. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $6.86 to $7.04 inclusive. The reporting person undertakes to provide the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.

Key Figures

Shares sold: 24,880 shares Weighted average sale price: $6.9637 per share Price range: $6.86–$7.04 per share +1 more

4 metrics

Shares sold 24,880 shares Open-market sale on reported Form 4 date

Weighted average sale price $6.9637 per share Common stock sale by CFO

Price range $6.86–$7.04 per share Multiple transactions within this range

Shares held after sale 493,557 shares Direct ownership following transaction

Key Terms

restricted stock awards, weighted average price, open-market sale, Form 4

4 terms

restricted stock awards financial

"tax obligations associated with the vesting of restricted stock awards"

Restricted stock awards are company shares given to employees or executives that cannot be sold or transferred until certain conditions — like staying with the company for a set time or meeting performance targets — are met, like a gift that is locked in a safe until rules are satisfied. Investors care because these awards tie management’s pay to company performance, can increase the number of shares outstanding when they become tradable (dilution), and may signal expected future selling pressure or commitment to long-term growth.

weighted average price financial

"The price reported in Column 4 is a weighted average price."

Weighted average price is the average price of a security where each trade or component is counted according to its size, so bigger trades pull the average more than smaller ones. Think of it like calculating the average cost of a grocery haul where items you bought more of have greater influence on the final per-item cost. Investors use it to understand the true average price paid or received, judge execution quality, and compare trading performance against market movement.

open-market sale financial

"transaction_action": "open-market sale""

An open-market sale is when a shareholder sells existing shares directly on a public exchange to any willing buyer, rather than through a private deal. Think of it like putting goods on a busy market stall where price is set by supply and demand; for investors it matters because such sales increase available supply, can put short-term downward pressure on the stock price, and signal changes in liquidity or investor confidence.

Form 4 regulatory

"The sale reported in this Form 4 was to cover tax obligations"

Form 4 is a official document that company insiders, such as executives or major shareholders, file with regulators whenever they buy or sell company shares. It provides transparency about how those with inside knowledge are trading, helping investors see if insiders are confident in the company's prospects or may be selling for personal reasons. This information can influence investor decisions by revealing insiders' perspectives on the company's value.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 4 Insider Transactions: What Each Field Means →

Available on EDGAR 07/09/2026 - 07:25 PM Accepted by SEC EDGAR 07/09/2026 - 07:24 PM Learn about SEC filing dates

FAQ

What insider transaction did Abeona Therapeutics (ABEO) report for its CFO?

Abeona Therapeutics reported that CFO Joseph Walter Vazzano sold 24,880 shares of common stock. The sale was made in the open market and was specifically to cover tax obligations arising from the vesting of restricted stock awards.

At what price did the Abeona (ABEO) CFO sell his shares?

The CFO reported a weighted average sale price of $6.9637 per share. The filing states the trades occurred in multiple transactions at prices ranging from $6.86 to $7.04 per share, all on the same reported date.

How many Abeona (ABEO) shares does the CFO hold after this Form 4 sale?

Following the reported sale, the CFO directly holds 493,557 shares of Abeona common stock. This figure reflects his position after selling 24,880 shares to satisfy tax obligations associated with recently vested restricted stock awards.

Was the Abeona (ABEO) CFO sale related to taxes or a discretionary stock sale?

The filing states the sale was made to cover tax obligations from the vesting of restricted stock awards. This indicates the transaction was tax-related rather than a purely discretionary decision to reduce exposure to Abeona’s common stock.

What does the weighted average price mean in the Abeona (ABEO) CFO Form 4?

The weighted average price of $6.9637 reflects that the 24,880 shares were sold in multiple trades. These trades occurred at prices between $6.86 and $7.04 per share, and the insider offers to provide detailed trade-by-trade data upon request.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Vazzano Joseph Walter

(Last) (First) (Middle)

6555 CARNEGIE AVE., 4TH FLOOR

(Street)

CLEVELAND OHIO 44103

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
ABEONA THERAPEUTICS INC. [ ABEO ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Financial Officer

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
07/09/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	07/09/2026		S(1)		24,880	D	$6.9637(2)	493,557	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. The sale reported in this Form 4 was to cover tax obligations associated with the vesting of restricted stock awards.

2. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $6.86 to $7.04 inclusive. The reporting person undertakes to provide the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.

	/s/ Joseph Vazzano	07/09/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)